ZA91409B - Transdermal administration of zwitterionic drugs - Google Patents

Transdermal administration of zwitterionic drugs

Info

Publication number
ZA91409B
ZA91409B ZA91409A ZA91409A ZA91409B ZA 91409 B ZA91409 B ZA 91409B ZA 91409 A ZA91409 A ZA 91409A ZA 91409 A ZA91409 A ZA 91409A ZA 91409 B ZA91409 B ZA 91409B
Authority
ZA
South Africa
Prior art keywords
transdermal administration
zwitterionic drugs
zwitterionic
drugs
transdermal
Prior art date
Application number
ZA91409A
Other languages
English (en)
Inventor
Gerard Cesidio Mazzenga
Cesidio Mazzenga Gerard
Bret Berner
Berner Bret
Original Assignee
Ciba Geigy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy filed Critical Ciba Geigy
Publication of ZA91409B publication Critical patent/ZA91409B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA91409A 1990-01-22 1991-01-21 Transdermal administration of zwitterionic drugs ZA91409B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/468,388 US5073539A (en) 1990-01-22 1990-01-22 Transdermal administration of zwitterionic drugs

Publications (1)

Publication Number Publication Date
ZA91409B true ZA91409B (en) 1991-09-25

Family

ID=23859604

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA91409A ZA91409B (en) 1990-01-22 1991-01-21 Transdermal administration of zwitterionic drugs

Country Status (9)

Country Link
US (1) US5073539A (ja)
EP (1) EP0439430A3 (ja)
JP (1) JPH04297417A (ja)
KR (1) KR910014112A (ja)
AU (1) AU6934691A (ja)
CA (1) CA2034516A1 (ja)
IE (1) IE910192A1 (ja)
PT (1) PT96532A (ja)
ZA (1) ZA91409B (ja)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5374645A (en) * 1990-01-22 1994-12-20 Ciba-Geigy Corporation Transdermal administation of ionic pharmaceutically active agents via aqueous isopropanol
US5273756A (en) * 1991-08-23 1993-12-28 Cygnus Therapeutic Systems Transdermal drug delivery device using a membrane-protected microporous membrane to achieve delayed onset
EP0755244A1 (en) * 1994-04-13 1997-01-29 Novartis AG Temporally controlled drug delivery systems
DE19512181C2 (de) * 1995-03-31 2003-11-06 Hexal Pharma Gmbh Transdermales System mit Ramipril und/oder Trandolapril als ACE-Hemmer
IT1313585B1 (it) * 1999-07-30 2002-09-09 Neuroscienze S C A R L Uso di agonisti dei recettori gabab per la terapia di mantenimentodell'astinenza da nicotina in soggetti nicotino-dipendenti.
DE10033855A1 (de) * 2000-07-12 2002-01-31 Hexal Ag Matrixkontrolliertes transdermales System mit Sulfonsäuresalz eines ACE-Hemmers
CN100391462C (zh) 2001-06-18 2008-06-04 诺芬药品公司 增强的透皮给药系统
US6805878B2 (en) 2001-09-13 2004-10-19 Noven Pharmaceuticals, Inc. Transdermal administration of ACE inhibitors
DE10228680A1 (de) * 2002-06-27 2004-01-22 Holden Development Limited, Tortola Grundlage für transdermale Formulierungen (PTF)
DE102005058166A1 (de) 2005-12-05 2007-06-06 Hexal Ag Matrixkontrolliertes transdermales System mit Amin-Salzen der ACE-Hemmer-Dicarbonsäuren
US7848801B2 (en) * 2005-12-30 2010-12-07 Tti Ellebeau, Inc. Iontophoretic systems, devices, and methods of delivery of active agents to biological interface
CA2721135A1 (en) 2007-06-13 2008-12-24 Wayne State University Board Of Governors A zwitterion solution for low-volume therapeutic delivery
CA2721134C (en) 2007-06-13 2017-02-07 Wayne State University Board Of Governors A baclofen solution for low-volume therapeutic delivery
EP2162183B1 (de) * 2007-06-25 2019-06-26 AMW GmbH Elektrophoretisches transdermales applikationssystem
CN107583102B (zh) * 2017-10-01 2020-05-05 山东朱氏药业集团有限公司 一种两性离子水凝胶敷料及其制备和使用方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3797494A (en) * 1969-04-01 1974-03-19 Alza Corp Bandage for the administration of drug by controlled metering through microporous materials
US4575503A (en) * 1983-02-10 1986-03-11 Ciba-Geigy Corporation 3-Amino-[1]-benzazepin-2-one-1-alkanoic acids
US4866160A (en) * 1985-04-09 1989-09-12 The Administrators Of The Tulane Educational Fund Therapeutic decapeptides
JPS63253022A (ja) * 1987-04-08 1988-10-20 Nitto Electric Ind Co Ltd バクロフエン外用製剤
US4962105A (en) * 1987-10-19 1990-10-09 Ciba-Geigy Corporation Potentiation of antihypertensive effect of ace inhibitors
EP0359004A1 (en) * 1988-09-05 1990-03-21 Takeda Chemical Industries, Ltd. Transdermal therapeutic composition for the treatment of hypertension
EP0391462A1 (en) * 1989-04-05 1990-10-10 Janssen Pharmaceutica N.V. Synergistic compositions containing ketanserin

Also Published As

Publication number Publication date
PT96532A (pt) 1991-10-15
EP0439430A2 (en) 1991-07-31
KR910014112A (ko) 1991-08-31
IE910192A1 (en) 1991-07-31
EP0439430A3 (en) 1991-09-25
CA2034516A1 (en) 1991-07-23
US5073539A (en) 1991-12-17
AU6934691A (en) 1991-07-25
JPH04297417A (ja) 1992-10-21

Similar Documents

Publication Publication Date Title
EP0535111A4 (en) Transdermal administration of buprenorphine
GB9016789D0 (en) Medicament administering devices
AU627845B2 (en) Improvements in or relating to devices for administration of drugs or the like
ZA928011B (en) Transdermal administration of melatonin.
GB2255503B (en) Improved use of ß2-bronchodilator drugs
GB9219999D0 (en) Preparation of a medicament
GB9410236D0 (en) Cytotoxic drug therapy
EP0439430A3 (en) Transdermal administration of zwitterionic drugs
AU2782592A (en) Thermal enhancement of transdermal drug administration
EP0450986A3 (en) A percutaneous-administration-type pharmaceutical preparation of nitroglycerin
GB2256588B (en) Preparation for transdermal administration of procaterol
ZA898201B (en) Gestodene-containing agent for transdermal administration
GB9601186D0 (en) Administration of Drugs
AU2617288A (en) Pharmaceutical formulations for transdermal administration
HK1015681A1 (en) Rate-controlled transdermal administration of risperidone
AU8614291A (en) Device for administering drugs
GB9016056D0 (en) Transdermal medicine delivery devices
ZA934523B (en) Medicinal preparation
IL97215A0 (en) Transdermal administration of medicaments
EP0425968A3 (en) Novel multiple layer transdermal drug administration system
ZA888363B (en) Pharmaceutical composition for the parenteral administration of navelbine
GB9304549D0 (en) Apparatus for administration of drugs
DK429589D0 (da) Transdermalt laegemiddelpraeparat
IL94737A0 (en) System for transdermal administration of medicaments
GB8826891D0 (en) Administration of pharmaceutical products